News for Core One Labs Inc. (CLABD)

Vancouver, British Columbia, Canada - April 09, 2024 - Core One Labs Inc. , , , is pleased to announce that it will conduct a non-brokered private placement of units at a price of $0.15 per...

Core One Labs Inc. reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was CAD 0.069762 million compared to CAD...

a nematode strain containing a transgene responsible for progressive, adult-onset paralysis and are pleased to share the positive preliminary results. The preliminary results from Bio-Compound A...

Vancouver, British Columbia, Canada - July 19, 2023 - Core One Labs Inc. , , , commends the California Assembly Health Committee for its recent approval of a bill aimed at legalizing the...

Core One Labs Inc. (OTCQB: CLABF) (CSE:COOL)(Frankfurt:LD6), (WKN:A3CSSU) announced that it is in discussions with several pharmaceutical laboratories and research organizations to supply them with active pharmaceutical ingredient psilocybin to meet their p

Core One Labs Inc. (OTCQB: CLABF) (CSE:COOL)(Frankfurt:LD6) (WKN:A3CSSU) announced that its wholly-owned subsidiary, Awakened Biosciences Inc.

After a successful commercial production trial, life sciences biotech company Core One Labs Inc. (OTCQB: CLABF) is set to begin commercial production of its clinical-grade psilocybin at a Good Manufacturing Practices (GMP) facility in January 2023.

HomeNewsCompany NewsCore One Labs Announces Grant of Restricted Share Units Core One Labs Announces Grant of Restricted Share Units November 09, 2022 ... | November 9, 2022

Read Core One Labs (OTCMKTS:CLABD) Trading Up 6.2% at ETF Daily News

Life sciences biotech company Core One Labs Inc. (OTCQB: CLABF) signed a Letter of Intent with GMP-certified manufacturer Medelys Laboratories International Inc. for the manufacturing of its proprietary psychedelic active pharmaceutical ingredient (API) products.

Will Look to Advance its Psychedelic Based Formulations

VANCOUVER, British Columbia, March 19, 2022 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL ), (OTC: CLABF ), (Frankfurt: LD6 , WKN: A3CSSU) (the “…

Successful Breakthrough of Biosynthetic Psilocybin Production Method Progressing Quickly

Vancouver drug-research companies are seeking cheaper ways to produce psychedelic mushrooms, or the active ingredient psilocybin, to cater to new demand.

CORE ONE LABS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF... | February 28, 2022

CORE ONE LABS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE... | February 28, 2022